Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
In the latest session, BioNTech SE ADR (NASDAQ: BNTX) closed at $99.27 up 0.31% from its previous closing price of $98.96. In other words, the price has increased by $0.31 from its previous closing price. On the day, 0.51 million shares were traded. BNTX stock price reached its highest trading level at $99.98 during the session, while it also had its lowest trading level at $98.46.
Ratios:
For a deeper understanding of BioNTech SE ADR’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.34 and its Current Ratio is at 7.45. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on March 13, 2025, initiated with a Buy rating and assigned the stock a target price of $145.
On January 10, 2025, Truist started tracking the stock assigning a Buy rating and target price of $172.
On December 11, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $170.Wells Fargo initiated its Overweight rating on December 11, 2024, with a $170 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 27 ’25 when Richardson Ryan bought 26,500 shares for $114.00 per share.
Medine GmbH bought 1,000,000 shares of BNTX for $119,580,000 on Feb 20 ’25. On Feb 20 ’25, another insider, Poetting Sierk, who serves as the Officer of the company, bought 120,000 shares for $119.58 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BNTX now has a Market Capitalization of 23821920256 and an Enterprise Value of 7292501504. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.00 while its Price-to-Book (P/B) ratio in mrq is 1.19. Its current Enterprise Value per Revenue stands at 2.651 whereas that against EBITDA is -7.059.
Stock Price History:
The Beta on a monthly basis for BNTX is 1.04, which has changed by 0.079138994 over the last 52 weeks, in comparison to a change of 0.08275449 over the same period for the S&P500. Over the past 52 weeks, BNTX has reached a high of $131.49, while it has fallen to a 52-week low of $76.53. The 50-Day Moving Average of the stock is -13.22%, while the 200-Day Moving Average is calculated to be -5.40%.
Shares Statistics:
For the past three months, BNTX has traded an average of 755.54K shares per day and 927410 over the past ten days. A total of 239.97M shares are outstanding, with a floating share count of 236.22M. Insiders hold about 1.56% of the company’s shares, while institutions hold 20.66% stake in the company. Shares short for BNTX as of 1740700800 were 2815249 with a Short Ratio of 3.73, compared to 1738281600 on 2743162. Therefore, it implies a Short% of Shares Outstanding of 2815249 and a Short% of Float of 3.06.
